Business Dec 11, 2020
Why Japan is largely a spectator in the coronavirus vaccine race
by Osamu Tsukimori
A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.
National Dec 4, 2020
Japan-made coronavirus vaccines may not be available until 2022
Only one company in Japan is conducting a trial of a vaccine.
National / Science & Health Oct 29, 2020
Japan's Shionogi readies COVID-19 vaccine for December trial
by Rocky Swift
The firm plans to put its vaccine candidate into Phase 1 clinical trials in December and shift into Phase 2 by January.
Business / Corporate Oct 23, 2020
Japanese drug firm Shionogi hit by cyberattack and data breach
Japanese pharmaceutical firm Shionogi & Co. said Thursday that its Taiwanese subsidiary was hit by a cyberattack earlier this month leading to a data breach, although no information regarding the novel coronavirus vaccine it is currently developing was leaked. According to the company, import licenses ...
Business Jul 21, 2020
Shionogi to prepare coronavirus vaccine for 30 million by end of 2021
The drugmaker has tripled its initial target, raising output for a stable domestic supply to prepare for a resurgence of COVID-19 cases.
Business / Corporate Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
National / Science & Health | FOCUS Jun 3, 2020
Japan pushes homegrown coronavirus vaccines to secure supply
The government is concerned that foreign vaccines may be not widely available in the nation.
Business May 8, 2020
Drugmaker Shionogi rushing to launch coronavirus vaccine in 2021
It is rare to study production before getting the results of clinical trials, but the Japanese drugmaker wants a vaccine on the market as fast as possible.
Business Apr 27, 2020
Shionogi to develop coronavirus vaccine, with trials eyed for this year
Shionogi & Co. said Monday it will develop a vaccine for the novel coronavirus with the aim of starting clinical trials this year. The Osaka-based company has decided to develop a recombinant protein vaccine through its subsidiary UMN Pharma Inc. while also seeking to discover ...
National / Science & Health Feb 24, 2018
One-dose flu drug Xofluza gets nod from health ministry
by Tomoko Otake
Osaka-based drugmaker Shionogi & Co. has announced that the health ministry gave it approval to manufacture and market its new flu drug Xofluza, which requires only a single dose regardless of age. The drug, which has been approved in tablet form for use against the ...
Business / Corporate Sep 29, 2017
Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life
by Kanoko Matsuyama
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer. Now demand is taking off and drugmakers are introducing new products to a ...